Editor's Note: This dispatch from ACC.21 was written by Mark Belkin, MD, a cardiology fellow at the University of ... Empagliflozin, an SGLT2 inhibitor, significantly reversed left ventricular (LV) remodeling in a population of diabetic ... Biomarkers were useful in predicting specific causes of death in patients with atrial fibrillation ... The beta-blocker carvedilol showed some benefit for protecting against heart injury resulting from chemotherapy-induced ...